Free Trial

Cyclo Therapeutics (CYTHW) Competitors

$0.03 0.00 (0.00%)
As of 03/26/2025

CYTHW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Cyclo Therapeutics stock or one of its competitors? The main competitors of Cyclo Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Cyclo Therapeutics vs.

Cyclo Therapeutics (NASDAQ:CYTHW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, valuation and dividends.

In the previous week, Cyclo Therapeutics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Cyclo Therapeutics Neutral
180 Life Sciences Neutral

Cyclo Therapeutics and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Cyclo TherapeuticsN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cyclo Therapeutics$870.73KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Cyclo TherapeuticsN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

Cyclo Therapeutics beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Remove Ads
Get Cyclo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYTHW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CYTHW vs. The Competition

MetricCyclo TherapeuticsDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.21B$5.24B$7.07B
Dividend YieldN/A2.92%4.87%4.05%
P/E RatioN/A4.2421.2017.47
Price / SalesN/A513.87356.3585.24
Price / CashN/A10.2538.1634.64
Price / BookN/A6.236.233.79
Net IncomeN/A$20.70B$3.20B$247.10M
7 Day PerformanceN/A-3.71%-8.32%-7.32%
1 Month PerformanceN/A-5.81%-3.36%-10.20%
1 Year PerformanceN/A81.79%2.72%-7.41%

Cyclo Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CYTHW
Cyclo Therapeutics
N/A$0.03
flat
N/AN/A$0.00$870,725.000.009Gap Down
ATNFW
180 Life Sciences
N/A$0.01
+5.3%
N/A-18.8%$0.00N/A0.007Positive News
Gap Down
High Trading Volume
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.02
-8.7%
N/A-91.8%$0.00N/A0.002
AIMDW
Ainos
N/A$0.11
-8.3%
N/A+54.6%$0.00$20,729.000.0040Positive News
ALVOW
Alvotech
N/A$1.51
-3.2%
N/A-57.6%$0.00$391.87M0.004Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/A-42.9%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.06
-36.2%
N/A+107.7%$0.00$37.32M0.0070Positive News
Gap Down
BTMDW
biote
N/A$0.06
flat
N/A-86.1%$0.00$197.19M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.10
-1.8%
N/A-91.6%$0.00N/A0.008Positive News
Gap Down
CELUW
Celularity
N/A$0.04
-14.7%
N/A-15.6%$0.00$48.20M0.00220Positive News
Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:CYTHW) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners